
"AstraZeneca CEO considers moving primary listing to US market"
AstraZeneca CEO Considers Shifting Stock Listing to US
Pascal Soriot, the chief executive of AstraZeneca, has reportedly expressed interest in moving the company’s stock market listing from the UK to the US.
The head of Britain’s most valuable listed firm has privately discussed favoring a shift to New